David Templeton
Chief Tech/Sci/R&D Officer en N4 PHARMA PLC .
Fortuna: - $ al 31/03/2024
Perfil
David Templeton is currently the Executive Director & Technical Director at N4 Pharma Plc since 2019.
Previously, he worked as the Director-Clinical Pharmacology at Eisai Ltd.
(United Kingdom) from 2007 to 2010 and as the Head-Non Clinical Development at Celltech Ltd.
from 2003 to 2004.
He also held the position of Head-Biometrics at Merck Generics Ltd.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
N4 PHARMA PLC
-.--% | 31/12/2022 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de David Templeton
Empresas | Cargo | Inicio |
---|---|---|
N4 PHARMA PLC | Chief Tech/Sci/R&D Officer | 21/05/2019 |
Antiguos cargos conocidos de David Templeton.
Empresas | Cargo | Fin |
---|---|---|
Eisai Ltd. (United Kingdom)
Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Corporate Officer/Principal | 01/01/2010 |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Corporate Officer/Principal | 01/01/2004 |
Merck Generics Ltd.
Merck Generics Ltd. Pharmaceuticals: MajorHealth Technology Merck Generics Ltd. provides therapies and drug products. The private company is based in London, UK. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
N4 PHARMA PLC | Health Technology |
Empresas privadas | 3 |
---|---|
Eisai Ltd. (United Kingdom)
Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008. | Health Technology |
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Commercial Services |
Merck Generics Ltd.
Merck Generics Ltd. Pharmaceuticals: MajorHealth Technology Merck Generics Ltd. provides therapies and drug products. The private company is based in London, UK. | Health Technology |
- Bolsa de valores
- Insiders
- David Templeton